Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trends in all-cause mortality and inpatient and outpatient visits for ambulatory care sensitive conditions during the first year of the COVID-19 pandemic: A population-based study.
Kendzerska T, Zhu DT, Pugliese M, Manuel D, Sadatsafavi M, Povitz M, Stukel TA, To T, Aaron SD, Mulpuru S, Chin M, Kendall CE, Thavorn K, Robillard R, Gershon AS. Kendzerska T, et al. Among authors: thavorn k. J Hosp Med. 2022 Sep;17(9):726-737. doi: 10.1002/jhm.12920. Epub 2022 Aug 5. J Hosp Med. 2022. PMID: 35929531 Free PMC article.
Trends in outpatient and inpatient visits for separate ambulatory-care-sensitive conditions during the first year of the COVID-19 pandemic: a province-based study.
Kendzerska T, Zhu DT, Pugliese M, Manuel D, Sadatsafavi M, Povitz M, Stukel TA, To T, Aaron SD, Mulpuru S, Chin M, Kendall CE, Thavorn K, Robillard R, Gershon AS. Kendzerska T, et al. Among authors: thavorn k. Front Public Health. 2023 Dec 18;11:1251020. doi: 10.3389/fpubh.2023.1251020. eCollection 2023. Front Public Health. 2023. PMID: 38169852 Free PMC article.
A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD.
Cowan J, Mulpuru S, Abdallah SJ, Chopra A, Purssell A, McGuinty M, Alvarez GG, Giulivi A, Corrales-Medina V, MacFadden D, Boyle L, Hasimja D, Thavorn K, Mallick R, Aaron SD, Cameron DW. Cowan J, et al. Among authors: thavorn k. Int J Chron Obstruct Pulmon Dis. 2021 Dec 3;16:3275-3284. doi: 10.2147/COPD.S338849. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34887657 Free PMC article. Clinical Trial.
Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations.
Cowan J, Mulpuru S, Aaron S, Alvarez G, Giulivi A, Corrales-Medina V, Thiruganasambandamoorthy V, Thavorn K, Mallick R, Cameron DW. Cowan J, et al. Among authors: thavorn k. Pilot Feasibility Stud. 2018 Aug 11;4:135. doi: 10.1186/s40814-018-0327-z. eCollection 2018. Pilot Feasibility Stud. 2018. PMID: 30116551 Free PMC article.
Outcomes and Resource Utilization Among Patients Admitted to the Intensive Care Unit Following Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Warwick M, Fernando SM, Aaron SD, Rochwerg B, Tran A, Thavorn K, Mulpuru S, McIsaac DI, Thompson LH, Tanuseputro P, Kyeremanteng K; Resource Optimization Network. Warwick M, et al. Among authors: thavorn k. J Intensive Care Med. 2021 Sep;36(9):1091-1097. doi: 10.1177/0885066620944865. Epub 2020 Jul 28. J Intensive Care Med. 2021. PMID: 32720561
Mortality and costs following extracorporeal membrane oxygenation in critically ill adults: a population-based cohort study.
Fernando SM, Qureshi D, Tanuseputro P, Fan E, Munshi L, Rochwerg B, Talarico R, Scales DC, Brodie D, Dhanani S, Guerguerian AM, Shemie SD, Thavorn K, Kyeremanteng K. Fernando SM, et al. Among authors: thavorn k. Intensive Care Med. 2019 Nov;45(11):1580-1589. doi: 10.1007/s00134-019-05766-z. Epub 2019 Sep 16. Intensive Care Med. 2019. PMID: 31529353
293 results